Electra Therapeutics, Inc. Common stock (ETRA) is a publicly traded the market company. As of September 21, 2026, ETRA trades at $13.78 with a market cap of $809.58M and a P/E ratio of 0.00. ETRA moved +0.00% today. Year to date, ETRA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $13.25 to $15.50. Rallies surfaces ETRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ETRA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $13.78 |
| Market Cap | $809.58M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.50 |
| 52-Week Low | $13.25 |
| Volume | 4.88M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
ETRA analyst coverage data. Average price target: $0.00.